at an EBITDA level product price increase impact revenue and royalty costs only. if prices are 35% greater than contemplated in DFS i would expect a little more impact than A$30m/a
regardless, it's all up.
my take on the capital raise ... a defensive measure locking away a 10% friendly.
Capital Raise, page-36
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add STA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $138.9M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| STA (ASX) Chart |
Day chart unavailable